One-step nucleic acid amplification (OSNA): where do we go with it?

@article{Tamaki2016OnestepNA,
  title={One-step nucleic acid amplification (OSNA): where do we go with it?},
  author={Yasuhiro Tamaki},
  journal={International Journal of Clinical Oncology},
  year={2016},
  volume={22},
  pages={3-10}
}
The one-step nucleic acid amplification (OSNA) assay was initially developed for the intraoperative assessment of sentinel lymph node metastases in breast cancer. This assay measures cytokeratin 19 (CK19) mRNA copy number and is widely used in hospitals. The results of the IBCSG 23-01, ACOSOG Z0011, and AMAROS trials demonstrated that no further axillary dissection is required for patients with sentinel lymph nodes that tested positive for cancer, which has led to a decreasing trend in the need… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
3 Citations
61 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 61 references

assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method

  • S Okamoto, H Niikura, cancer Nakabayashi K et al Detection of sentinel lymph no cervical
  • Gynecol Oncol 130:530–536 10 Int J Clin Oncol
  • 2017

Similar Papers

Loading similar papers…